Skye Bioscience, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit and Redeemable Convertible Series B and Convertible Series C, D and F Preferred Stock - Preferred Stock(Detail Textuals 1)

Stockholders' Deficit and Redeemable Convertible Series B and Convertible Series C, D and F Preferred Stock - Preferred Stock(Detail Textuals 1) - USD ($)		1 Months Ended									3 Months Ended	12 Months Ended
	Nov. 01, 2017	Dec. 28, 2017	Nov. 30, 2017	Oct. 31, 2017	Feb. 28, 2017	Jan. 31, 2017	Dec. 29, 2016	Oct. 31, 2016	Mar. 31, 2016	Aug. 31, 2015	Mar. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Mar. 31, 2017	Aug. 20, 2015
Equity [Line Items]
Common Stock, Par or Stated Value Per Share											$ 0.001	$ 0.001
Preferred Stock, Shares Authorized											20,000,000
Number of shares issued in conversion											900,000
Warrant exercise price (in dollars per share)													$ 0.25
Common Stock
Equity [Line Items]
Common Stock, Par or Stated Value Per Share														$ 0.001
Conversion price										$ 0.80
Number of shares converted										1,250
Warrants
Equity [Line Items]
Number of warrants issued					125,000
Warrant exercise price (in dollars per share)					$ 0.41
Term of warrant					5 years
Series B Preferred Stock
Equity [Line Items]
Number of preferred stock and warrants sold										5,000
Aggregate purchase price										$ 1,000
Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants										$ 5,000,000
Conversion price	$ 0.15	$ 0.10	$ 0.10				$ 0.25	$ 0.40	$ 0.80	$ 0.10	$ 0.10	$ 0.25
Number of shares converted				777.125						28,335,500	2,833.55	420.325
Number of shares issued in conversion				3,108,500							28,335,500	2,802,167
Warrant exercise price (in dollars per share)			0.15
Reduction of conversion price of preferred stock			0.15
Liquidation preference value												$ 2,833,550
Percentage of conversion amount										115.00%
Value of final judgment rendered against company										$ 100,000
Preferred stock, conversion rate				4000:1							10,000:1	6666.67:1
Shares issued, price per share (in dollars per share)														0.25	$ 0.80
Series B Preferred Stock \| Warrants
Equity [Line Items]
Warrant exercise price (in dollars per share)		$ 1.15
Term of warrant		5 years
Convertible Series D Preferred Stock
Equity [Line Items]
Number of preferred stock and warrants sold						1,200
Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants						$ 1,200,000
Conversion price	$ 0.15	$ 0.10				$ 0.25					$ 0.10	$ 0.25
Number of shares converted											200	1,000
Number of shares issued in conversion											2,000,000	4,000,000
Warrant exercise price (in dollars per share)							0.25						0.25
Reduction of conversion price of preferred stock			$ 0.15			$ 0.25
Preferred stock, conversion rate											10,000:1	4000:1
Number of common stock issued upon conversion of preferred stock						4,000
Liquidation provision common stock equivalent shares												2,000,000
Liquidation provision common stock equivalent value												$ 200,000
Beneficial conversion feature upon issuance of Series C Preferred Stock						$ 536,000		$ 175,000
Shares issued, price per share (in dollars per share)												$ 0.10		$ 0.25
Convertible Series D Preferred Stock \| Warrants
Equity [Line Items]
Number of warrants issued						480,000
Warrant exercise price (in dollars per share)						$ 0.25	$ 0.25
Term of warrant						5 years
Redeemable Convertible Series F Preferred Stock
Equity [Line Items]
Number of preferred stock and warrants sold			2,000
Aggregate purchase price			$ 1,000
Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants			$ 2,000,000
Conversion price		0.10	$ 0.15								$ 0.10	0.15
Number of shares converted											2,000
Number of shares issued in conversion											20,000,000
Warrant exercise price (in dollars per share)		$ 0.10	$ 0.15
Percentage of conversion amount			130.00%
Value of final judgment rendered against company			$ 100,000
Preferred stock, conversion rate											10,000:1
Number of common stock issued upon conversion of preferred stock			6,666.67
Beneficial conversion feature upon issuance of Series C Preferred Stock		$ 333,333
Percentage of shares to be redeemed			150.00%
Proceeds from triggering transaction			$ 6,000,000
Redemption amount percentage			50.00%
Convertible Series C Preferred Stock
Equity [Line Items]
Number of preferred stock and warrants sold								500
Aggregate purchase price								$ 1,000
Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants								$ 500,000
Conversion price								$ 0.40				$ 0.25	$ 0.25
Number of shares converted												386
Number of shares issued in conversion												1,544,000
Warrant exercise price (in dollars per share)								$ 0.40
Reduction of conversion price of preferred stock						$ 0.25
Preferred stock, conversion rate												4000:1
Number of common stock issued upon conversion of preferred stock								2,500
Liquidation provision common stock equivalent shares								1,250,000
Beneficial conversion feature upon issuance of Series C Preferred Stock								$ 325,000